| 000 | 01787 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516133415.0 | ||
| 264 | 0 | _c20131211 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1097-6760 | ||
| 024 | 7 |
_a10.1016/j.annemergmed.2012.10.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDart, Richard C | |
| 245 | 0 | 0 |
_aA randomized, double-blind, placebo-controlled trial of a highly purified equine F(ab)2 antibody black widow spider antivenom. _h[electronic resource] |
| 260 |
_bAnnals of emergency medicine _cApr 2013 |
||
| 300 |
_a458-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntivenins _xtherapeutic use |
| 650 | 0 | 4 | _aBlack Widow Spider |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPain _xetiology |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aSpider Bites _xcomplications |
| 650 | 0 | 4 |
_aSpider Venoms _xantagonists & inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBogdan, Gregory | |
| 700 | 1 | _aHeard, Kennon | |
| 700 | 1 | _aBucher Bartelson, Becki | |
| 700 | 1 | _aGarcia-Ubbelohde, Walter | |
| 700 | 1 | _aBush, Sean | |
| 700 | 1 | _aArnold, Tom | |
| 700 | 1 | _aClark, Richard C | |
| 700 | 1 | _aHendey, Gregory W | |
| 700 | 1 | _aHolstege, Christopher | |
| 700 | 1 | _aSpradley, Elizabeth A | |
| 773 | 0 |
_tAnnals of emergency medicine _gvol. 61 _gno. 4 _gp. 458-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.annemergmed.2012.10.008 _zAvailable from publisher's website |
| 999 |
_c22476461 _d22476461 |
||